Literature DB >> 3611075

Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.

J M Braughler, J F Pregenzer, R L Chase, L A Duncan, E J Jacobsen, J M McCall.   

Abstract

Two representative compounds from a novel chemical series of potent inhibitors of lipid peroxidation are described. The compounds 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16 alpha-methylpregna-1,4,9(11)-triene-3,20-dione monomethane sulfonate (U74006F) and 21-[4-(3,6-bis(diethylamino)-2-pyridinyl)-1-piperazinyl]-16 alpha-methylpregna-1,4,9(11)triene-3,20-dione hydrochloride (U74500A) inhibited lipid peroxidation in brain homogenates and purified brain synaptosomes under a variety of conditions involving iron. With IC50 values ranging from 2 to 60 microM, U74006F and U74500A were comparable in potency to alpha-tocopherol or butylated hydroxytoluene and were nearly 100 times as potent as desferrioxamine. Some specificity for intact phospholipid membranes is suggested since the ability of U74006F or U74500A to inhibit lipid peroxidation was greatly reduced in methanol solutions of arachidonic acid. Despite close similarities in their structures, their response to increasing concentrations of Fe2+ in lipid peroxidation assays differed qualitatively. One of the compounds, U74500A, may act as a membrane localized chelator of iron.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611075

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  The role of oxidative stress in diseases caused by mineral dusts and fibres: current status and future of prophylaxis and treatment.

Authors:  M Gulumian
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 2.  Medical treatments of acute spinal cord injury.

Authors:  W Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

3.  Selegiline and the Treatment of Parkinson's Disease: How patients can benefit from drug therapy.

Authors:  J S Richardson
Journal:  Can Fam Physician       Date:  1991-05       Impact factor: 3.275

4.  Human neutrophil NADPH-oxidase activity is inhibited by lazaroids.

Authors:  A J Theron; R Anderson
Journal:  Inflammation       Date:  1996-04       Impact factor: 4.092

Review 5.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

6.  Lazaroid U74006F for canine small bowel preservation.

Authors:  N Hamada; S Zhang; M Nomoto; Y Zhu; A Nemoto; Y Kawashima; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1996-10       Impact factor: 1.066

7.  Comparison of various lazaroid compounds for protection against ischemic liver injury.

Authors:  N Ishizaki; Y Zhu; S Zhang; A Nemoto; Y Kobayashi; V M Subbotin; R G Lee; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

8.  Attenuation of acute inflammatory effects of silica in rat lung by 21-aminosteroid, U74389G.

Authors:  J M Antonini; K van Dyke; M DiMatteo; M J Reasor
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

9.  Investigation of an inhibitor of lipid peroxidation U74006F on tumor growth and protein extravasation in the C6 astrocytoma spheroid implantation glioma model.

Authors:  J F Megyesi; C L Farrell; R F Del Maestro
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

10.  Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation.

Authors:  A Rabinovitch; W L Suarez; P D Thomas; K Strynadka; I Simpson
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.